Genetic Technologies Ltd (ASX: GTG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Genetic Technologies Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Genetic Technologies Ltd (ASX: GTG)
Latest News
⏸️ Investing
Market wipeout: Stocks crushed in $24 billion rush for the exits
⏸️ Investing
4 stocks soaring on the ASX today
⏸️ Investing
Genetic Technologies Limited soars 30%: Here's why
GTG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Genetic Technologies Ltd
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.
GTG Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
28 Nov 2023 | $0.00 | $0.00 | 0.00% | 528,546 | $0.00 | $0.00 | $0.00 |
27 Nov 2023 | $0.00 | $0.00 | 0.00% | 2,000,108 | $0.00 | $0.00 | $0.00 |
24 Nov 2023 | $0.00 | $0.00 | 0.00% | 205,268 | $0.00 | $0.00 | $0.00 |
23 Nov 2023 | $0.00 | $0.00 | 0.00% | 10,344,828 | $0.00 | $0.00 | $0.00 |
22 Nov 2023 | $0.00 | $0.00 | 0.00% | 106,181,477 | $0.00 | $0.00 | $0.00 |
21 Nov 2023 | $0.00 | $0.00 | 0.00% | 3,251,225 | $0.00 | $0.00 | $0.00 |
20 Nov 2023 | $0.00 | $0.00 | 0.00% | 2,117,331 | $0.00 | $0.00 | $0.00 |
17 Nov 2023 | $0.00 | $0.00 | 0.00% | 2,525,236 | $0.00 | $0.00 | $0.00 |
16 Nov 2023 | $0.00 | $0.00 | 0.00% | 3,001,560 | $0.00 | $0.00 | $0.00 |
15 Nov 2023 | $0.00 | $0.00 | 0.00% | 50,000 | $0.00 | $0.00 | $0.00 |
13 Nov 2023 | $0.00 | $0.00 | 0.00% | 129,520 | $0.00 | $0.00 | $0.00 |
10 Nov 2023 | $0.00 | $0.00 | 0.00% | 285,000 | $0.00 | $0.00 | $0.00 |
09 Nov 2023 | $0.00 | $0.00 | 0.00% | 495,209 | $0.00 | $0.00 | $0.00 |
08 Nov 2023 | $0.00 | $0.00 | 0.00% | 28,816 | $0.00 | $0.00 | $0.00 |
07 Nov 2023 | $0.00 | $0.00 | 0.00% | 410,000 | $0.00 | $0.00 | $0.00 |
06 Nov 2023 | $0.00 | $0.00 | 0.00% | 66,658 | $0.00 | $0.00 | $0.00 |
03 Nov 2023 | $0.00 | $0.00 | 0.00% | 3,698,000 | $0.00 | $0.00 | $0.00 |
02 Nov 2023 | $0.00 | $0.00 | 0.00% | 150,000 | $0.00 | $0.00 | $0.00 |
01 Nov 2023 | $0.00 | $0.00 | 0.00% | 2,357,125 | $0.00 | $0.00 | $0.00 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
30 Jan 2023 | Jerzy (George) Muchnicki | Sell | 38,400,000 | $55,898 |
On-market trade. US$
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Nicholas (Nick) Jon Burrows | Non-Executive Director | Sep 2019 |
Mr. Burrows has over 30 years' of experience .He is a independent Non-Executive Director across the Listed, government and private sectors with expertise in corporate governance, and strategic, commercial, financial and risk management oversight, underpinned by his background as a chartered accountant. Mr. Burrows was Chief Financial Officer and Company Secretary of Tassal Group Limited for 21 years from 1988 to 2009, and accordingly brings to the Board independent C suite commercial experience and the benefits of an senior executive ASX200 listed entity background. Mr Burrows current and past Board and advisory portfolio encompasses listed and regulated entities, government business enterprises, state-owned and local government entities and authorities, large private/ family companies community organizations, membership-based bodies and Not-for-Profits. Mr Burrows' expertise spans a raft of industry sectors encompassing water and sewerage, infrastructure, renewable energy, forestry, agribusiness, public transport, tourism and hospitality, education and the vocational education sector, aquaculture, civil engineering, construction, and finance and valuations.
|
Dr Lindsay Peter Wakefield | Non-Executive Director | Sep 2014 |
Dr Wakefield started Safetech Pty Ltd in 1985 and over the next 25 years, Safetech became a force in the Australian material handling and lifting equipment market, designing and manufacturing a range of industrial products. In 1993, he left medicine to become the full time CEO of Safetech. In 2006, Safetech was awarded the Telstra Australian National Business of the Year. In 2013, Safetech merged and ultimately acquired Tiemen Materials Handling. Dr Wakefield continues as the CEO of Safetech. It is Australia's largest manufacturer and supplier of dock equipment, freight hoists and custom lifting solutions. Safetech employs approximately 100 people. Dr Wakefield has been a biotech investor for more than 20 years
|
Dr Jerzy (George) Muchnicki | Executive Director | Jan 2018 |
Dr Muchnicki acted as Interim Chief Executive Officer from September 2019 till the appointment of Mr. Simon Morriss to the role. For the past 14 years, he has been involved in commercialization and funding R&D in the biotechnology sector from gene silencing to regenerative medicine. Dr Muchnicki brings with him commercial and medical skills, including broad interests in software development, blockchain and sustainable building materials. He is a co-founder and Non-Executive Director of Speed Panel Holdings a world leader in fire rated and acoustic wall solutions. He is also the co-founder of Candlebets, a software development company that is creating blockchain enabled platforms for the gaming industry.
|
Mr Peter Irwin Rubinstein | Non-Executive ChairmanNon-Executive Director | Jan 2018 |
Mr Rubinstein has over 20 years' experience in early-stage technology commercialization through to public listings on the ASX. He is a lawyer, having worked at a national firm prior to moving in-house at Montech, the commercial arm of Monash University. Mr. Rubinstein has had exposure to the creation, launch and management of a diverse range of technology companies in biotech, digital payments and renewable energy.
|
Mr Tony Di Pietro | Chief Financial OfficerCompany Secretary | Oct 2022 |
-
|
Mr Michael (Mike) Tonroe | Company Secretary | Aug 2021 |
-
|
Mr Simon Morriss | Chief Executive Officer | Feb 2021 |
-
|
Carl Stubbings | Chief Commercial Officer |
-
|
|
Simon Morriss | Chief Executive Officer |
-
|
|
Simon Morriss | Chief Executive Officer |
-
|
|
Kevin Camilleri | Chief Executive Officer of EasyDNA |
-
|
|
Tony Di Pietro | Chief Financial OfficerCompany Secretary |
-
|
|
Michael (Mike) Tonroe | Company Secretary |
-
|
|
Richard Allman | Scientific Advisor former Chief Scientific Officer |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Hsbc Custody Nominees (Australia) Limited | 8,119,123,510 | 70.35% |
Mr Warwick Wright | 217,500,000 | 1.88% |
Mjgd Nominees Pty Ltd | 200,849,309 | 1.74% |
Doma 193 Pty Ltd <Doma 193 A/C> | 144,551,379 | 1.25% |
Rip Opportunities Pty Ltd <Pir Super Fund A/C> | 124,999,999 | 1.08% |
Irwin Biotech Nominees Pty Ltd <Bioa A/C> | 75,849,310 | 0.66% |
Ap 300 Pty Ltd <Ap Invest A/C> | 48,040,000 | 0.42% |
Monument Hill Pty Ltd | 42,000,001 | 0.36% |
Miss Susan Spiteri | 40,142,778 | 0.35% |
Mrs Helen Kamer & Mr Benjamin Kamer <Kamer Super Fund A/C> | 40,000,000 | 0.35% |
Mr Lei Da Tao | 38,000,000 | 0.33% |
Bnp Paribas Nominees Pty Ltd Acf Clearstream | 35,043,531 | 0.30% |
Aquasafe Investments Pty Ltd <White Superfund A/C> | 30,608,028 | 0.27% |
Whalecorp Pty Ltd <Whalecorp Pty Ltd S/F A/C> | 30,000,000 | 0.26% |
Miss Beverley Susan Mccain | 28,000,000 | 0.24% |
Mr John Christopolous <Chrisand Family A/C> | 27,000,000 | 0.23% |
Mr Bill Gianoulas | 25,000,000 | 0.22% |
Mr Michael Battley | 24,221,459 | 0.21% |
Citicorp Nominees Pty Limited | 23,257,576 | 0.20% |
Mr Can Odabas | 23,000,000 | 0.20% |